Navigation Links
New Topical Patent Research Reports Recently Published at

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd informs that new in-demand market reports featuring drugs patent researches have been added to its catalogue "Drugs & Biotechnology."

Each of the recently published reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

New market patent research reports include:

  • Sevelamer - Comprehensive Patent Search
  • Sildenafil - Comprehensive Patent Search
  • Silodosin - Comprehensive Patent Search
  • Sorafenib - Comprehensive Patent Search
  • Sunitinib - Comprehensive Patent Search
  • Tadalafil - Comprehensive Patent Search
  • Tazobactam - Comprehensive Patent Search
  • Tenofovir - Comprehensive Patent Search
  • Terbinafine - Comprehensive Patent Search
  • Ulipristal - Comprehensive Patent Search
  • Valaciclovir - Comprehensive Patent Search
  • Varenicline - Comprehensive Patent Search
  • Voriconazole - Comprehensive Patent Search

  • Each Patent Search features:

  • Comprehensive patent searching, covering the world's key territories;
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques;
  • Patent identification, categorisation and interpretation;
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims;
  • Manual filtration of patents not relevant to generic development;
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation;
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers.

  • Patent categories identified in each report encompass molecular form, active ingredient preparation, formulations & methods thereof, related medical use & administration, active ingredient combinations, analytical methods.

    More new recent market research reports on Drugs & Biotechnology can be found at Market Publishers, Ltd.Mrs. Alla MartinTel: +44 208 123 2220Fax: +44 207 900

    SOURCE The Market Publishers, Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
    2. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
    3. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
    4. Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
    5. Topical erectile dysfunction therapy shows promise
    6. Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens
    7. Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
    8. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
    9. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
    10. Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks
    11. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
    Post Your Comments:
    (Date:6/27/2016)...  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, announced today ... States denied its petition to review decisions ... U.S. Patent No. 6,258,540 (",540 Patent") are not patent ... Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  ...
    (Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
    (Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
    (Date:6/23/2016)... ... June 23, 2016 , ... ... announce the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The ... is proud to add Target to its list of well-respected retailers. This list ...
    Breaking Biology Technology:
    (Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
    (Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
    (Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
    Breaking Biology News(10 mins):